Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Javier Díez‐Domingo

Biographic Data

ID7756691
NAMEJavier Díez‐Domingo
GIVEN NAMESJavier
FAMILY NAMEDíez‐Domingo
SIGNATUREDOMINGO J D
AFFILIATIONSFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
ORCID0000-0003-1008-3922
VERIFIEDYes
TOTAL WORKS14
TOTAL CITATIONS0
WORKS AS AUTHOR14
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2010
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe

    Open Access•Anke L Stuurman, Antonio Losa Carmona et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…

  • Co‐creation of information materials within the assent process

    Open Access•Jaime Fons‐Martinez, Cristina Ferrer‐Albero et al.•ARTICLE•Health Expectations•2023

    INTRODUCTION: The informed consent process is key to safeguarding the autonomy of the participant in medical research. For this process to be valid, the information presented to the potential participant should meet their needs and be understood by them. The i-CONSENT project has developed 'Guidelines for adapting the informed consent process in clinical trials' which aim to improve informed consent so that they are easier to understand and bette…

  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019

    Open Access•You Li, Xin Wang et al.•ARTICLE•The Lancet•2022

    BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory infection in young children. We previously estimated that in 2015, 33·1 million episodes of RSV-associated acute lower respiratory infection occurred in children aged 0-60 months, resulting in a total of 118 200 deaths worldwide. Since then, several community surveillance studies have been done to obtain a more precise estimation of RSV associated co…

  • Keys to improving the informed consent process in research

    Open Access•Jaime Fons‐Martinez, Cristina Ferrer‐Albero et al.•ARTICLE•Health Expectations•2022

    The ethical and legal governance of all aspects of informed consent in research is becoming increasingly extensive and complex. Instead of a single directive, informed consent is governed by a series of international rules applied to biomedical research, clinical trials and biobanks, while various ethical guidelines for research have been published by different international bodies. Informed consent is an essential part of any research involving …

  • Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of Gaia Case Definitions

    Open Access•Antonio Losa Carmona, Antonio Carmona et al.•ARTICLE•International Journal of…•2022

    Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Sa…

  • A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018–19 season

    Open Access•Javier Díez‐Domingo, Javier Díez-Domingo et al.•ARTICLE•BMC Public Health•2022

    The Gripómetro is a robust research method that provides real-time data and trends for influenza vaccine coverage along with other useful information related to vaccination such as intention to vaccinate, motivation and barriers to vaccination

  • Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain

    Open Access•Ángel Gil-de-Miguel, Ángel Gil de Miguel et al.•ARTICLE•BMC Public Health•2022

    Season 2017/2018 was associated with a considerable burden of influenza in Spain, which increased with age and presence of comorbidities. Individuals with comorbidities accounted for most of the costs of influenza. Results suggest that population aged 18-64 years old is generating the highest share of costs to the NHS when all healthcare costs are considered. Preventive strategies targeting subjects with comorbidities, regardless of age, should b…

  • Impact of a Gender-Neutral HPV Vaccination Program in Men Who Have Sex with Men (MSM)

    Open Access•Javier Díez‐Domingo, Víctor Sánchez‐Alonso et al.•ARTICLE•International Journal of…•2021

    A major challenge in human papillomavirus (HPV) vaccine programs is the universal gender-neutral recommendation, as well as estimation of its long-term effect. The objective of this study is to predict the added benefit of male vaccination, especially in men who have sex with men (MSM), and to analyze the impact of the program on society. We propose a mathematical model of the HPV infection based on a network paradigm. Data from Spain allowed con…

  • Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season

    Open Access•Ainara Mira‐Iglesias, F Xavier López‐Labrador et al.•ARTICLE•International Journal of…•2021

    Influenza vaccination is annually recommended for specific populations at risk, such as older adults. We estimated the 2018/2019 influenza vaccine effectiveness (IVE) overall, by influenza subtype, type of vaccine, and by time elapsed since vaccination among subjects 65 years old or over in a multicenter prospective study in the Valencia Hospital Surveillance Network for the Study of Influenza and other Respiratory Viruses (VAHNSI, Spain). Inform…

  • Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the Covid-19 Emergence

    Open Access•Antonio Losa Carmona, Antonio Carmona et al.•ARTICLE•International Journal of…•2021

    The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public-private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative). It was initiated as a response to the guidance on influenza vaccines by EMA (European Medicines Agency), which advised vaccine manufacturers to wor…

  • Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

    Open Access•Víctor Baselga-Moreno, С В Трушакова et al.•ARTICLE•BMC Public Health•2019

    Vaccination prevented around 1 in 4 hospitalisations with influenza. Sparse numbers didn't allow estimating IVE in all sites separately. Pregnancy was found a risk factor for influenza, having 3 times more risk of being admitted with influenza for pregnant women

  • Determinants of seasonal influenza vaccination in pregnant women in Valencia, Spain

    Open Access•Rafael Vila‐Candel, Pedro Navarro‐Illana et al.•ARTICLE•BMC Public Health•2016

    Pregnant women in Spain declined to be vaccinated due to under-estimation of the risk of contracting or being harmed by influenza, and lack of information. Interventions aiming to optimize vaccination coverage should include information addressing the safety and effectiveness of the current vaccine together with improved professional training and motivation

  • Knowledge and attitudes of Spanish adolescent girls towards human papillomavirus infection

    Open Access•Pedro Navarro‐Illana, Pedro Navarro-Illana et al.•ARTICLE•BMC Public Health•2014

    Knowledge about HPV infection and vaccine was fair in adolescents of Valencia, and is independent to the number of contacts with the health system, it is however correlated to the conversations about the vaccine with their peers and the vaccination status. An action to improve HPV knowledge through health providers might increase vaccine coverage in the adolescents

  • Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain

    Open Access•Javier Díez‐Domingo, Javier Díez-Domingo et al.•ARTICLE•BMC Public Health•2010

    A rotavirus vaccination programme with RotaTeq would reduce significantly the important medical and economic burden of RVGE in Spain

No prominent works on this page.

  • Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain

    Open Access•Javier Díez‐Domingo, Javier Díez-Domingo et al.•ARTICLE•BMC Public Health•2010

    A rotavirus vaccination programme with RotaTeq would reduce significantly the important medical and economic burden of RVGE in Spain

  • Knowledge and attitudes of Spanish adolescent girls towards human papillomavirus infection

    Open Access•Pedro Navarro‐Illana, Pedro Navarro-Illana et al.•ARTICLE•BMC Public Health•2014

    Knowledge about HPV infection and vaccine was fair in adolescents of Valencia, and is independent to the number of contacts with the health system, it is however correlated to the conversations about the vaccine with their peers and the vaccination status. An action to improve HPV knowledge through health providers might increase vaccine coverage in the adolescents

  • Determinants of seasonal influenza vaccination in pregnant women in Valencia, Spain

    Open Access•Rafael Vila‐Candel, Pedro Navarro‐Illana et al.•ARTICLE•BMC Public Health•2016

    Pregnant women in Spain declined to be vaccinated due to under-estimation of the risk of contracting or being harmed by influenza, and lack of information. Interventions aiming to optimize vaccination coverage should include information addressing the safety and effectiveness of the current vaccine together with improved professional training and motivation

  • Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

    Open Access•Víctor Baselga-Moreno, С В Трушакова et al.•ARTICLE•BMC Public Health•2019

    Vaccination prevented around 1 in 4 hospitalisations with influenza. Sparse numbers didn't allow estimating IVE in all sites separately. Pregnancy was found a risk factor for influenza, having 3 times more risk of being admitted with influenza for pregnant women

  • Impact of a Gender-Neutral HPV Vaccination Program in Men Who Have Sex with Men (MSM)

    Open Access•Javier Díez‐Domingo, Víctor Sánchez‐Alonso et al.•ARTICLE•International Journal of…•2021

    A major challenge in human papillomavirus (HPV) vaccine programs is the universal gender-neutral recommendation, as well as estimation of its long-term effect. The objective of this study is to predict the added benefit of male vaccination, especially in men who have sex with men (MSM), and to analyze the impact of the program on society. We propose a mathematical model of the HPV infection based on a network paradigm. Data from Spain allowed con…

  • Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season

    Open Access•Ainara Mira‐Iglesias, F Xavier López‐Labrador et al.•ARTICLE•International Journal of…•2021

    Influenza vaccination is annually recommended for specific populations at risk, such as older adults. We estimated the 2018/2019 influenza vaccine effectiveness (IVE) overall, by influenza subtype, type of vaccine, and by time elapsed since vaccination among subjects 65 years old or over in a multicenter prospective study in the Valencia Hospital Surveillance Network for the Study of Influenza and other Respiratory Viruses (VAHNSI, Spain). Inform…

  • Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the Covid-19 Emergence

    Open Access•Antonio Losa Carmona, Antonio Carmona et al.•ARTICLE•International Journal of…•2021

    The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public-private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative). It was initiated as a response to the guidance on influenza vaccines by EMA (European Medicines Agency), which advised vaccine manufacturers to wor…

  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019

    Open Access•You Li, Xin Wang et al.•ARTICLE•The Lancet•2022

    BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory infection in young children. We previously estimated that in 2015, 33·1 million episodes of RSV-associated acute lower respiratory infection occurred in children aged 0-60 months, resulting in a total of 118 200 deaths worldwide. Since then, several community surveillance studies have been done to obtain a more precise estimation of RSV associated co…

  • Keys to improving the informed consent process in research

    Open Access•Jaime Fons‐Martinez, Cristina Ferrer‐Albero et al.•ARTICLE•Health Expectations•2022

    The ethical and legal governance of all aspects of informed consent in research is becoming increasingly extensive and complex. Instead of a single directive, informed consent is governed by a series of international rules applied to biomedical research, clinical trials and biobanks, while various ethical guidelines for research have been published by different international bodies. Informed consent is an essential part of any research involving …

  • Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of Gaia Case Definitions

    Open Access•Antonio Losa Carmona, Antonio Carmona et al.•ARTICLE•International Journal of…•2022

    Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Sa…

  • A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018–19 season

    Open Access•Javier Díez‐Domingo, Javier Díez-Domingo et al.•ARTICLE•BMC Public Health•2022

    The Gripómetro is a robust research method that provides real-time data and trends for influenza vaccine coverage along with other useful information related to vaccination such as intention to vaccinate, motivation and barriers to vaccination

  • Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain

    Open Access•Ángel Gil-de-Miguel, Ángel Gil de Miguel et al.•ARTICLE•BMC Public Health•2022

    Season 2017/2018 was associated with a considerable burden of influenza in Spain, which increased with age and presence of comorbidities. Individuals with comorbidities accounted for most of the costs of influenza. Results suggest that population aged 18-64 years old is generating the highest share of costs to the NHS when all healthcare costs are considered. Preventive strategies targeting subjects with comorbidities, regardless of age, should b…

  • Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe

    Open Access•Anke L Stuurman, Antonio Losa Carmona et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…

  • Co‐creation of information materials within the assent process

    Open Access•Jaime Fons‐Martinez, Cristina Ferrer‐Albero et al.•ARTICLE•Health Expectations•2023

    INTRODUCTION: The informed consent process is key to safeguarding the autonomy of the participant in medical research. For this process to be valid, the information presented to the potential participant should meet their needs and be understood by them. The i-CONSENT project has developed 'Guidelines for adapting the informed consent process in clinical trials' which aim to improve informed consent so that they are easier to understand and bette…

Medicine (14 works) · Vaccination (9 works) · Internal Medicine (8 works) · Environmental health (7 works) · Immunology (7 works) · Influenza Virus Research Studies (7 works) · Pediatrics (7 works) · Public health (7 works) · Biostatistics (6 works) · Influenza vaccine (6 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae